Ardelyx, Inc. (ARDX)
3.775
+0.04
(+0.94%)
USD |
NASDAQ |
Aug 25, 16:00
3.775
0.00 (0.00%)
After-Hours: 16:59
Ardelyx Price to Book Value : 6.312 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.253 |
| August 21, 2026 | 6.504 |
| August 20, 2026 | 6.521 |
| August 19, 2026 | 6.738 |
| August 18, 2026 | 6.554 |
| August 17, 2026 | 6.788 |
| August 14, 2026 | 6.788 |
| August 13, 2026 | 6.538 |
| August 12, 2026 | 6.638 |
| August 11, 2026 | 6.588 |
| August 10, 2026 | 6.688 |
| August 07, 2026 | 6.688 |
| August 06, 2026 | 8.143 |
| August 05, 2026 | 8.210 |
| August 04, 2026 | 8.377 |
| August 03, 2026 | 8.326 |
| July 31, 2026 | 8.276 |
| July 30, 2026 | 8.427 |
| July 29, 2026 | 8.360 |
| July 28, 2026 | 8.502 |
| July 27, 2026 | 8.460 |
| July 24, 2026 | 8.410 |
| July 23, 2026 | 8.577 |
| July 22, 2026 | 8.494 |
| July 21, 2026 | 8.510 |
| Date | Value |
|---|---|
| July 20, 2026 | 8.510 |
| July 17, 2026 | 8.694 |
| July 16, 2026 | 8.569 |
| July 15, 2026 | 8.862 |
| July 14, 2026 | 8.628 |
| July 13, 2026 | 8.594 |
| July 10, 2026 | 8.828 |
| July 09, 2026 | 8.995 |
| July 08, 2026 | 9.079 |
| July 07, 2026 | 8.995 |
| July 06, 2026 | 8.928 |
| July 02, 2026 | 8.811 |
| July 01, 2026 | 8.628 |
| June 30, 2026 | 8.527 |
| June 29, 2026 | 8.691 |
| June 26, 2026 | 9.223 |
| June 25, 2026 | 10.07 |
| June 24, 2026 | 10.29 |
| June 23, 2026 | 10.27 |
| June 22, 2026 | 10.59 |
| June 18, 2026 | 10.05 |
| June 17, 2026 | 9.705 |
| June 16, 2026 | 9.422 |
| June 15, 2026 | 9.447 |
| June 12, 2026 | 9.455 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| REGENXBIO, Inc. | 6.721 |
| ACADIA Pharmaceuticals, Inc. | 4.029 |
| Alnylam Pharmaceuticals, Inc. | 23.70 |
| Anika Therapeutics, Inc. | 2.098 |
| Savara, Inc. | 7.992 |
Price to Book Value Related Metrics
| PS Ratio | 2.050 |
| Price | 3.775 |
| Earnings Yield | -5.99% |
| Market Cap | 940.53M |